Innovative pharmaceutical company 60 Degrees Pharmaceuticals faced mounting challenges with SEC reporting as manual data consolidation, fragmented document ownership, and escalating EDGARization costs slowed filings and increased operational risk.
This case study shows how 60 Degrees Pharmaceuticals transformed its SEC reporting process by adopting a centralized, data-centric disclosure management approach with IRIS CARBON®.